IRMD · Nasdaq · CIK 0001325618

IRADIMED CORP

IRADIMED CORP’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G/A filed on Oct 27, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $83.8M and net income of $22.5M, according to its XBRL data on EDGAR. Its EDGAR record lists 50 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$83.8M
Net income, FY2025
$22.5M
Form 4 filings on record, past 12 months
50

Company overview

Legal name (as filed)
IRADIMED CORP
Ticker
IRMD
SEC Central Index Key (CIK)
0001325618
Business address
ORLANDO, FL
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer<br>Smaller reporting company
Position in SEC ticker list
#2347 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from IRADIMED CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$41.8MFY2021$53.3MFY2022$65.6MFY2023$73.2MFY2024$83.8MFY2025
Net income
$9.3MFY2021$12.8MFY2022$17.2MFY2023$19.2MFY2024$22.5MFY2025
IRMD annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$41.8M$53.3M$65.6M$73.2M$83.8M
Net income$9.3M$12.8M$17.2M$19.2M$22.5M
Diluted EPS$0.74$1.02$1.35$1.50$1.75
Total assets$82.9M$85.5M$92.2M$98.3M$108.8M
Cash and equivalents$62.0M$58.0M$49.8M$52.2M$51.2M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

IRMD latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 6, 202610-KAnnual report· period Dec 31, 2025Document · Index
Jul 31, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 31, 20268-KOther events· period Jul 31, 2026Document · Index
Apr 30, 2026DEF 14ADefinitive proxy statement· period Jun 23, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about IRADIMED CORP, by form type:

4 ×22144 ×48-K ×4SCHEDULE 13G/A ×310-Q ×28-K/A ×1SCHEDULE 13G ×1ARS ×1DEF 14A ×110-K ×1
IRMD recent filings
FiledFormWhat it isOriginal
Oct 27, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Sep 25, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 23, 2026Document · Index
Sep 8, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 3, 2026Document · Index
Sep 3, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 18, 20268-K/AResults of operations· period Jul 31, 2026Document · Index
Jul 31, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 31, 20268-KOther events· period Jul 31, 2026Document · Index
Jul 28, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jun 24, 20268-KShareholder vote results· period Jun 24, 2026Document · Index
Jun 23, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 20, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 4, 2026Document · Index
Jun 4, 2026144Notice of proposed sale of securitiesDocument · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
May 28, 20264Statement of changes in beneficial ownership (insider trade)· period May 26, 2026Document · Index
May 20, 20264Statement of changes in beneficial ownership (insider trade)· period May 18, 2026Document · Index
May 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 13, 20264Statement of changes in beneficial ownership (insider trade)· period May 11, 2026Document · Index
May 6, 20264Statement of changes in beneficial ownership (insider trade)· period May 4, 2026Document · Index
May 1, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 1, 20268-KResults of operations· period May 1, 2026Document · Index
Apr 30, 2026ARSARS· period Dec 31, 2025Document · Index
Apr 30, 2026DEF 14ADefinitive proxy statement· period Jun 23, 2026Document · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 27, 2026Document · Index
Apr 22, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 20, 2026Document · Index
Apr 15, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 13, 2026Document · Index
Apr 7, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 6, 2026Document · Index
Apr 1, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 30, 2026Document · Index
Mar 25, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 23, 2026Document · Index
Mar 18, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 16, 2026Document · Index
Mar 10, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 9, 2026Document · Index
Mar 9, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 6, 2026Document · Index
Mar 6, 2026144Notice of proposed sale of securitiesDocument · Index
Mar 6, 202610-KAnnual report· period Dec 31, 2025Document · Index
Mar 5, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 3, 2026Document · Index
Mar 5, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 3, 2026Document · Index
Feb 13, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 13, 2026Document · Index
Feb 13, 2026144Notice of proposed sale of securitiesDocument · Index
Feb 10, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Feb 10, 20268-KResults of operations· period Feb 10, 2026Document · Index
Jan 27, 20264Statement of changes in beneficial ownership (insider trade)· period Jan 26, 2026Document · Index

Insider filing activity

50 Form 4 filings appear in IRADIMED CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Florida

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001325618 and XBRL company facts. IRADIMED CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.